MAP-tau quantification in cell lysates
This HTRF kit enables the cell-based detection of phosphorylated TAU at Serine 422, as a marker of neurodegenerative diseases.
The HTRF Phospho-TAU (Ser422) cell-based assay kit is ideal for quantifying endogenous phospho-TAU phosphorylated on Serine 422. TAU exists in different states in both Alzheimer’s (AD) and Parkinson’s (PD) Diseases.
TAU hyperphosphorylation is also a marker for multiple neurodegenerative diseases and CNS disorders.
The Phospho-TAU (Ser422) assay measures TAU when phosphorylated at Ser422. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer.
The Phospho-TAU (Ser422) assay uses 2 labeled antibodies: one with a donor fluorophore, and the other with an acceptor. The first antibody was selected for its specific binding to the phosphorylated motif on the protein, and the second for its ability to recognize the protein independently from its phosphorylation state. Protein phosphorylation enables an immune-complex formation involving both labeled antibodies, and which brings the donor fluorophore into close proximity to the acceptor, thereby generating a FRET signal. Its intensity is directly proportional to the concentration of phosphorylated protein present in the sample, and provides a means of assessing the protein’s phosphorylation state under a no-wash assay format.
The 2 plate protocol involves culturing cells in a 96-well plate before lysis, then transferring the lysates to a 384-well low volume detection plate before the addition of Phospho-TAU (Ser422) HTRF detection reagents.
This protocol enables the cells' viability and confluence to be monitored.
Detection of Phosphorylated TAU (Ser422) with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required.
This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.
Human SH-SY5Y cells were plated at 100,000 cells/well in a 96-well plate. After 24 h incubation at 37 °C, 5% CO2, the cells were treated with increasing concentrations of GSK3α/β inhibitor BIO (6-bromoindirubin-3-oxime) for 1 h, followed by 2 h Okadaic acid (100nM) and 10 min Calyculin A (100nM) treatments. Then the medium was removed and 50 µL of supplemented lysis buffer 1X were added. After 30min lysis at RT under gentle shaking, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF phospho-Tau (Ser422) or total Tau detection reagents were added. The HTRF signal was recorded after an overnight incubation.
BIO-induced GSK3α/β inhibition leads to a complete inhibition of Tau phosphorylation on Serine 422, whereas the Tau expression level remains stable in the same experimental conditions.
Mouse Neuro2a cells were plated at 100,000 cells/well in a 96-well plate. After 24 h incubation at 37 °C, 5% CO2, the cells were treated with increasing concentrations of GSK3α/β inhibitor BIO (6-bromoindirubin-3-oxime) for 1 h, followed by 2 h Okadaic acid (100nM) and 10 min Calyculin A (100nM) treatments. Then the medium was removed and 50 µL of supplemented lysis buffer 1X were added. After 30min lysis at RT under gentle shaking, 16 µL of lysate were transferred into a 384-well low volume white microplate and 4 µL of the HTRF phospho-Tau (Ser422) or total Tau detection reagents were added. The HTRF signal was recorded after an overnight incubation.
As in SH-SY5Y cells, BIO-induced GSK3α/β inhibition leads to an inhibition of Tau phosphorylation on Serine 422, whereas the total Tau kit is human specific only.
Human Neuroblastoma SH-SY5Y cells were seeded in a T175 flask in complete culture medium and incubated for 2 days at 37°C, 5% CO2. Then, Cells were treated with Okadaic acid (100 nM) for 2 h and Calyculin A (100 nM) for 10 min. Following these treatments, Cells were lysed with 3 mL of supplemented lysis buffer#1 for 30min at RT under gentle shaking. Soluble supernatants were collected after a 10 minutes centrifugation.
Serial dilutions of the cell lysate were performed in the supplemented lysis buffer and 16 µL of each dilution were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF HTRF phospho-Tau (Ser422) detection reagents. Equal amounts of lysates were used for a side by side comparison between Western Blot and HTRF.
This result demonstrates that the HTRF phospho-Tau (Ser422) assay is 4-fold more sensitive than the Western Blot, at least under these experimental conditions.
Tau has a prominent role in the pathogenesis of Alzheimer's Disease. It becomes hyperphosphorylated and aggregates, forming filaments, which can further condense into neurofibrillary tangles. Tau aggregates may propagate pathology by spreading from cell to cell in a prion-like manner. Drugs modulating Tau hyperphosphorylation and reducing Tau aggregation are viable therapeutic approaches.
The physiological role of Tau protein is to promote the assembly and stability of microtubules. Six isoforms of Tau have been described, ranging from 352 to 441 residues coming from exons 2, 3, and 10, that are alternatively spliced. The longest isoform of Tau (Tau-441) contains 85 putative phosphorylation sites, half of which have been confirmed experimentally.
Changes in CREB and ERK phosphorylation levels after beta-amyloid treatment - Application Notes
HTRF and WB compatible guidelines - Technical Notes
Mastering the art of cell signaling assays optimization - Guides
A fun video introducing you to phosphorylation assays with HTRF - Videos
Insider Tips for successful sample treatment - Technical Notes
Alpha Synuclein kits, perfect tools to study synucleinopathy - Posters
LRRK2 kit, a game changer in neuroscience - Posters
Get the brochure about technology comparison. - Brochures
Protocol for tumor xenograft analysis with HTRF - Technical Notes
Multi-tissue cellular modeling and anlysis of insulin signaling - Posters
A solution for phospho-protein analysis in metabolic disorders - Posters
Detailed protocol and direct comparison with WB - Posters
A single technology for 2D cells, 3D cells, and xenograft models - Posters
PI3K/AKT/mTor translational control pathway - Posters
Analysis of a large panel of diverse biological samples and cellular models - Posters
One technology across all samples - Application Notes
Tumor xenograft analysis: HTRF versus Western blot - Application Notes
Valuable guidelines for efficiently analyzing and interpreting results - Application Notes
Increased flexibility of phospho-assays - Application Notes
Analyse of PI3K/AKT/mTor translational control pathway - Application Notes
In collaboration with Bayer - Scientific Presentations
The essential guide for extending your knowledge on the molecular mechanisms of neurodegenerative diseases - Guides
Physiologically relevant results fo fast flowing research - Flyers
Discover this infographic design on neurodegenerative diseases - Infographics
Seeding and lysing recommendations for a number of cell culture vessels. - Technical Notes
Combination of AlphaLISA®, HTRF®, or AlphaLISA® SureFire® Ultra™ immunoassays with the ATPlite™ 1step cell viability assay - Application Notes
Learn how to reduce time and sample consumption - Application Notes
Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.Let's find your reader
Phospho-TAU (Ser202/Thr205) cellular kit
Simple, all-in-one kit for robust detection of Phospho-TAU S202/T205
Phospho-Tau (Ser356) cellular kit
Simple, all-in-one HTRF kit for robust detection of Phospho-TAU S356